Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study ...
National Geographic news

LED light therapy for skin is trendy—but does it work?

Dermatologists explain the science behind wildly popular treatments like red light therapy, which is now available at home—for a steep price. Full-face LED masks like this one can cost up to several ...